Chemokines such as SDF-1 and fractalkine are considered interesting therapeutic targets to fight against obesity-induced inflammatory complications; however, detailed molecular mechanisms underlying the chemokine-mediated interglial crosstalk in obesity-induced hypothalamic inflammation remain to be further investigated. Here, CXCL12 is linked to obesity due to melanocortin 4 receptor deficiency.